Susceptibility of diverse primary HIV isolates with varying co-receptor specificity's to CXCR4 antagonistic compounds

This publication has 24 references indexed in Scilit:

• Entry of R5X4 and X4 Human Immunodeficiency Virus Type 1 Strains Is Mediated by Negatively Charged and Tyrosine Residues in the Amino-Terminal Domain and the Second Extracellular Loop of CXCR4
  Virology, 2000
• CHEMOKINE RECEPTORS AS HIV-1 CORECEPTORS: Roles in Viral Entry, Tropism, and Disease
  Annual Review of Immunology, 1999
• Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry
  Nature Medicine, 1998
• Evidence for the HIV-1 phenotype switch as a causal factor in acquired immunodeficiency
  Nature Medicine, 1998
• AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor
  Nature Medicine, 1998
• Co-receptors for HIV-1 entry
  Current Opinion in Immunology, 1997
• Change in Coreceptor Use Correlates with Disease Progression in HIV-1–Infected Individuals
  The Journal of Experimental Medicine, 1997
• The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1
  Nature, 1996
• The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
  Nature, 1996
• Synthesis and Structure-Activity Relationships of Phenylenebis(methylene)-Linked Bis-Tetraazamacrocycles That Inhibit HIV Replication. Effects of Macrocyclic Ring Size and Substituents on the Aromatic Linker
  Journal of Medicinal Chemistry, 1995